Connor, Clark & Lunn Investment Management Ltd. - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$13,662,814
+36.3%
149,976
-1.3%
0.07%
+25.9%
Q1 2023$10,025,590
+152.2%
151,995
+97.7%
0.05%
+134.8%
Q4 2022$3,975,517
+995.2%
76,881
+1346.8%
0.02%
+1050.0%
Q3 2022$363,000
-18.4%
5,314
-43.5%
0.00%0.0%
Q4 2021$445,000
-82.6%
9,406
-87.9%
0.00%
-84.6%
Q3 2021$2,554,000
+119.4%
77,495
+320.7%
0.01%
+116.7%
Q2 2021$1,164,00018,4210.01%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders